Menéndez-Arias, L., J. Tözsér, and S. Oroszlan. 1998. Moloney murine leukemia virus retropepsin. In Handbook of Proteolytic Enzymes (A.J. Barrett, N.D. Rawlings, and J.F. Woessner, Jr., eds.), Academic Press, pp. 946-949.
Menéndez-Arias, L., J. Tözsér, and S. Oroszlan. 1998. Mouse mammary tumor virus retropepsin. In Handbook of Proteolytic Enzymes (A.J. Barrett, N.D. Rawlings, and J.F. Woessner, Jr., eds.), Academic Press, pp. 944-946.
Tözsér, J., L. Menéndez-Arias, and S. Oroszlan. 1998. Equine infectious anemia virus retropepsin. In Handbook of Proteolytic Enzymes (A.J. Barrett, N.D. Rawlings, and J.F. Woessner, Jr., eds.), Academic Press, pp. 932-935.
Kubota, S., S. Oroszlan, and M. Hatanaka. 1994. The origin of human immunodeficiency virus type-1 rev gene. An evolutionary hypothesis. FEBS Lett. 338:118-121.
Levin, J.G., D.L. Hatfield, S. Oroszlan, and A. Rein. 1993. Mechanisms of translational suppression used in the biosynthesis of reverse transcriptase. In Reverse Transcriptase (S. Goff and A.M. Skalka, eds.), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 5-31.
Oroszlan, S., J. Tözsér, and I.T. Weber. 1993. The proteinases of bovine leukaemia and equine infectious anaemia virus. Antiviral News 1:22-23.
Roller, P.P., M. Nomizu, S.W. Snyder, S. Oroszlan, and J.B. McMahon. 1992. Complementary peptides as inhibitors of HIV-1 protease. In Peptides: Chemistry and Biology (J.A. Smith and J.E. Rivier, eds.), Escom, The Netherlands, pp. 709-710.
Copeland, T.D., I. Bláha, J. Tözsér, and S. Oroszlan. 1992. Totally synthetic retroviral proteins: Proteases and nucleic acid binding proteins. In Peptides: Chemistry and Biology (J.A. Smith and J.E. Rivier, eds.), Escom, The Netherlands, pp. 717-718.
Hatfield, D.L., J.G. Levin, A. Rein, and S. Oroszlan. 1992. Translational suppression in retroviral gene expression. Adv. Virus Res. 41:193-239.
Roberts, M.M., E. Volker, T.D. Copeland, K. Nagashima, M.B. Cassell, C.J. Briggs, and S. Oroszlan. 1991. Regulated proteolytic processing within mature retroviral capsids. In Advances in Molecular Biology and Targeted Treatment for AIDS (A. Kumar, ed.), Plenum Publishing Corp., New York, NY, pp. 273-280.
Roberts, M.M., and S. Oroszlan. 1990. The action of retroviral protease in various phases of virus replication. In Retroviral Proteases, "Control of Maturation and Morphogenesis" (L. Pearl, ed.), Macmillan Press, London, England, pp. 131-139.
Hatfield, D., B.J. Lee, D.W.E. Smith, and S. Oroszlan. 1990. Role of nonsense, frameshift, and missense suppressor tRNAs in mammalian cells. In Progress in Molecular and Subcellular Biology (P. Jeanteur, Y. Kuchino, W.E.G. Müller, and P.L. Paine, eds.), Springer-Verlag, New York, NY, pp. 115-146.
Oroszlan, S., and J. Tözsér. 1990. The retroviral proteinases. Sem. Virol. 1:369-378.
Hatfield, D., and S. Oroszlan. 1990. The where, what and how of ribosomal frameshifting in retroviral protein
synthesis. Trends Biochem. Sci. 15:186-190.
Oroszlan, S., and R.B. Luftig. 1990. Retroviral proteinases. Curr. Top. Microbiol. Immunol. 157:153-185.
Hatfield, D.L., D.W. Smith, B.J. Lee, P.J. Worland, and S. Oroszlan. 1990. Structure and function of suppressor tRNAs in higher eukaryotes. Crit. Rev. Biochem. Mol. Biol. 25:71-96.
Oroszlan, S. 1989. Biosynthesis and proteolytic processing of retroviral proteins: An overview. In Current Communications in Molecular Biology: Viral Proteinases as Targets for Chemotherapy (H.-G. Krausslich, S. Oroszlan, and E. Wimmer, eds.), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 87-100.
Blumenstein, J.J., R. Luftig, M. Bu, T.D. Copeland, C.J. Michejda, and S. Oroszlan. 1989. Non-peptide inhibitor of HIV proteinase. Synthetic analogs of cerulenin. In Current Communications in Molecular Biology: Viral Proteinases as Targets for Chemotherapy (H.-G. Krausslich, S. Oroszlan, and E. Wimmer, eds.), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 211-214.
Louis, J.M., E.M. Wondrak, C.A.D. Smith, P.T. Mora, and S. Oroszlan. 1989. E. coli-expressed HIV-1 proteinase mutants containing Arg87/Asn88 substitutions are inactive. In Current Communications in Molecular Biology: Viral Proteinases as Targets for Chemotherapy (H.-G. Krausslich, S. Oroszlan, and E. Wimmer, eds.), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 161-167.
Roberts, M.M., and S. Oroszlan. 1989. Action of viral proteinase packaged in capsids of equine infectious anemia virus. In Current Communications in Molecular Biology: Viral Proteinases as Targets for Chemotherapy (H.-G. Krausslich, S. Oroszlan, and E. Wimmer, eds.), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 101-105.
Copeland, T.D., L.E. Henderson, R. Gorelick, Y. Kim, and S. Oroszlan. 1988. Chemical synthesis of a retroviral nucleic acid binding protein. In Peptide, Chemistry and Biology (G.R. Marshall, ed.), Escom, Leiden, The Netherlands, pp. 420-421.
Henderson, L.E., T.D. Copeland, R.C. Sowder, A.M. Schultz, and S. Oroszlan. 1988. Analysis of proteins and peptides purified from sucrose gradient banded HTLV-III. In Human Retroviruses, Cancer, and AIDS: Approaches to Prevention and Therapy, Vol. 71 (D. Bolognesi, ed.), Alan R. Liss, New York, NY, pp. 135-147.
Schultz, A.M., L.E. Henderson, and S. Oroszlan. 1988. Fatty acylation of proteins. Annu. Rev. Cell Biol. 4:611-647.
Oroszlan, S. 1986. Summary Report of The United States – Japan Cooperative Cancer Research Program Seminar on "Regulation and Expression and Function of Transformation-Related Genes." Progress Report, April 1985 through March 1986, pp. 66-69.
Schultz, A.M., S. Sallay, and S. Oroszlan. 1985. A totally synthetic peptide antigen possessing two distinct antigenic determinants of retroviral p30. In Synthetic Peptides in Biology and Medicine (K. Alitalo et al., eds.), Elsevier, Amsterdam, The Netherlands, pp. 59-65.
Oroszlan, S., and R.V. Gilden. 1985. Antigenic structure of retroviruses. In Immunochemistry of Viruses. The Basis for Serodiagnosis and Vaccines (M.H.V. van Regenmortel and A.R. Neurath, eds.), Elsevier, Amsterdam, The Netherlands, pp.447-466.
Oroszlan, S., and T.D. Copeland. 1985. Primary structure and processing of gag and env gene products of human T-cell leukemia viruses HTLV-ICR and HTLV-IATK. In Current Topics in Microbiology and Immunology (P.K. Vogt, ed.), Springer-Verlag, Berlin, Germany,
pp. 221-233.
Copeland, T.D., K.A. Smith, and S. Oroszlan. 1984. Characterization of immunoaffinity-purified human T-cell growth factor from Jurkat cells. In Thymic Hormones and Lymphokines (A. Goldstein, ed.), Plenum Press, New York, NY, pp. 181-189.
Oroszlan, S., T.D. Copeland, V.S. Kalyanaram, M.G. Sarngadharan, A.M. Schultz, and R.C. Gallo. 1984. Chemical analysis of human T-cell leukemia virus structural proteins. In Human T-Cell Leukemia-Lymphoma Viruses (R.C. Gallo, M.E. Essex, and L. Gross, eds.), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 101-110.
Sallay, S.I., and S. Oroszlan. 1984. A model study for monitoring merrified solid-phase peptide synthesis through N-2,4-dinitrophenyl derivatization. Handbook of HPLC for Separation of Amino Acids, Peptides, and Proteins, Vol. II (W.S. Hancock, ed.), CRC Press, Boca Raton, FL, pp. 99-110.
Gilden, R.V., N.R. Rice, R.M. Stephens, R.R. Hiebsch, and S. Oroszlan. 1984. Origins of the structural and transforming (rel) genes of reticuloendotheliosis virus (REV). In Gene Transfer and Cancer (M. Pearson and N. Sternberg, eds.), Raven, New York, NY, pp. 163-167.
Oroszlan, S., T.D. Copeland, N.R. Rice, G.W. Smythers, W.P. Tsai, Y. Yoshinaka, and K. Shimotohno. 1984. Structural and antigenic characterization of the proteins of human T-cell leukemia viruses and their relationships to the gene products of other retroviruses. Princess Takamatsu Symp. 15:147-157.
Schultz, A.M., L.E. Henderson, and S. Oroszlan. 1983. Myristylation of gag polyproteins of type B, C, and D retroviruses and also of retroviral transforming proteins. In Leukemia Reviews International, Vol. 1 (M.A. Rich, ed.), Marcel Dekker, New York, NY, pp. 304-305.
Sarngadharan, M.G., J. Schuepbach, V.S. Kalyanaraman, M. Robert-Guroff, S. Oroszlan, and R.C. Gallo. 1983. Immunological characterization of the natural antibodies to human T-cell leukemia virus in human sera. In Modern Trends in Human Leukemia, Vol. 28 (R. Neth et al., eds.), Springer-Verlag, Berlin/Heidelberg, Germany, pp. 498-503.
Gilden, R.V., N.R. Rice, R.M. Stephens, R.R. Hiebsch, and S. Oroszlan. 1982. The relationship of reticuloendotheliosis virus to other retroviruses and cellular genes. In Advances in Comparative Leukemia Research (D.S. Yohn and J.R. Blakeslee, eds.), Elsevier/North Holland, New York, NY, pp. 329-330.
Henderson, L.E., R.C. Sowder, and S. Oroszlan. 1982. Reversed phase (RP) HPLC of proteins and peptides and its impact on protein microsequencing. In Methods in Protein Sequence Analysis (M. Elzinga, ed.), Humana, Clifton, NJ, pp. 409-416.
Copeland, T.D., and S. Oroszlan. 1982. A synthetic dodecapeptide substrate for type C RNA tumor virus-associated proteolytic enzyme. In Peptides: Synthesis, Structure, Function (D.H. Rich and E. Gross, eds.), Pierce Chemical Co., Rockford, IL, pp. 497-500.
Gilden, R.V., S. Oroszlan, H.A. Young, N.R. Rice, M.A. Gonda, M. Cohen, and A.R. Rein. 1981. Genetics of retrovirus-host interactions. In Frontiers in Immunogenetics (W.H. Hildemann, ed.), Elsevier/North Holland, New York, NY, pp. 191-223.
Henderson, L.E., R. Sowder, and S. Oroszlan. 1981. Protein and peptide purification by reversed-phase high-pressure chromatography using volatile solvents. In Chemical Synthesis and Sequencing of Peptides and Proteins (D.T. Liu, A.N. Schechter, R.L. Heinrikson, and P.G. Condliffe, eds.), Elsevier, Amsterdam, The Netherlands, pp. 251-260.
Oroszlan, S., L.E. Henderson, T.D. Copeland, A.M. Schultz, and E.M. Rabin. 1980. Processing and structure of murine leukemia virus gag and env gene encoded polyproteins. In Biosynthesis, Modification and Processing of Cellular and Viral Polyproteins (G. Koch and D. Richter, eds.), Academic Press, New York, NY, pp. 219-233.
Oroszlan, S., and R.V. Gilden. 1980. Primary structure analysis of retrovirus proteins. In Molecular Biology of RNA Tumor Viruses (J.R. Stephenson, ed.), Academic Press, New York, NY, pp. 299-344.
Sallay, S., K.S.L. Srivastava, S. Oroszlan, and R.V. Gilden. 1979. Improved preparation of acid stable supports for solid-phase peptide synthesis. In Peptides (E. Gross and J. Meienhofer, eds.), Pierce Chemical Co., Rockford, IL, pp. 377-380.
Sallay, S., and S. Oroszlan. 1979. A model study for monitoring merrified solid phase peptide synthesis by high-pressure liquid chromatography. In Biological Biomedical Applications of Liquid Chromatography, Vol. I (G.L. Hawk, ed.), Marcel-Dekker, New York, NY, pp. 199-224.
Oroszlan, S., and R.V. Gilden. 1979. Amino acid sequences of plant and animal viral proteins. In Comprehensive Virology, Vol. 13 (H. Fraekel-Conrat and R.W. Wagner, eds.), Plenum, New York, NY, pp. 1-35.
Oroszlan, S., and R.V. Gilden. 1978. Immune lysis of type C viruses by antisera to purified viral subunits. In Advances in Comparative Leukemia Research (P. Bentvelzen et al., eds.), Elsevier/North Holland, New York, NY, pp. 90-93.
Oroszlan, S., T. Copeland, M. Summers, and G. Smythers. 1975. Automated microsequence analysis in the presence of double carrier: Application to viral structural proteins. In Solid-Phase Methods in Protein Sequence Analysis (R.A. Laursen, ed.), Pierce Chemical Co., Rockford, IL, pp. 179-192.
Gilden, R.V., and S. Oroszlan. 1972. Group-specific antigens of RNA tumor viruses as markers for subinfectious
expression of the RNA virus genome. Proc. Natl. Acad. Sci. USA 69:1021-1025.
Gilden, R.V., and S. Oroszlan. 1971. Structural and immunologic relationships among mammalian C-type viruses. J. Am. Vet. Med. Assoc. 158(Suppl. 2):1099.